Skip to main content

Clinical

By Tom Sullivan | 12:06 pm | May 03, 2016
IBM Watson said it will provide free storage to nonprofit organizations and academic medical center researchers using Apple’s ResearchKit. But developers looking to tap into the supercomputer's analytics will have to pay.
By Bernie Monegain | 10:05 am | May 03, 2016
The funding will span more than 20 projects to address several of healthcare’s biggest burdens, according to the Patient-Centered Outcomes Research Institute.
By Mike Miliard | 12:32 pm | May 02, 2016
The technology, seen as a potential move toward bionics, could one day enable wireless updates for corrective lens prescriptions, if it comes to fruition.
By Jeff Lagasse | 12:06 pm | May 02, 2016
The health system credits clinical and financial improvements to a CDI initiative that resulted in more accurate coding and greater physician engagement. 
By Kaiser Health News | 11:38 am | May 02, 2016
The sheer number and variety of providers that patients see after leaving a hospital make medical mistakes and poor transitions in care all too common today. 
By Bill Siwicki | 11:59 am | April 27, 2016
By and large, population health measurement efforts are poorly developed and uncoordinated – and without effective measurement success will remain elusive, says Georgetown's Michael A. Stoto.
By Bernie Monegain | 11:12 am | April 27, 2016
Geisinger Health System has enlisted 100,000 people for its genomic study and did so more quickly than expected. Attracting so many volunteers over two years has prompted program executives to raise the bar to 250,000 or more participants.
By Bill Siwicki | 10:43 am | April 27, 2016
CloudMedx, a big data health analytics company, has acquired Gyrus Labs to extend its CloudMedx Analytics Platform, which is designed to help improve patient care through data insights.
By Bernie Monegain | 04:28 pm | April 26, 2016
Truven Health Analytics prides itself on, well, analyzing data.
Electronic Health Records
By Jessica Davis | 05:05 pm | April 22, 2016
Officials uncovered 'significant risks' and irregularities during rollout, raising concerns about a viable final product, a spokesperson says.